BioNxt Solutions Inc.
BNXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.70K | 19.80K | 30.90K | 22.70K | 153.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.70K | 19.80K | 30.90K | 22.70K | 153.80K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 16.70K | 19.80K | 30.90K | 22.70K | 153.80K |
| SG&A Expenses | 2.68M | 2.16M | 2.29M | 2.06M | 2.95M |
| Depreciation & Amortization | 45.80K | 67.10K | 82.40K | 101.60K | 125.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55M | 3.27M | 3.97M | 3.80M | 4.89M |
| Operating Income | -3.54M | -3.25M | -3.94M | -3.77M | -4.74M |
| Income Before Tax | -4.15M | -3.95M | -4.77M | -4.74M | -5.78M |
| Income Tax Expenses | -64.10K | -64.10K | -- | -- | -- |
| Earnings from Continuing Operations | -4.09 | -3.88 | -4.77 | -4.74 | -5.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.09M | -3.88M | -4.77M | -4.74M | -5.78M |
| EBIT | -3.54M | -3.25M | -3.94M | -3.77M | -4.74M |
| EBITDA | -3.47M | -3.19M | -3.88M | -3.69M | -4.63M |
| EPS Basic | -0.04 | -0.03 | -0.04 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.04 | -0.03 | -0.04 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 451.52M | 445.13M | 437.31M | 423.11M | 411.75M |
| Average Diluted Shares Outstanding | 451.52M | 445.13M | 437.31M | 423.11M | 411.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |